ファブリー病治療薬の世界市場規模調査＆予測：治療法、投与経路、流通チャネル、地域別分析、2022-2029年

ライソゾーム貯蔵障害は、ファブリー病を含む疾患の一種です。

腎臓、心臓、皮膚、その他の臓器に影響を及ぼすことがある珍しい遺伝性疾患です。患者は、α-ガラクトシダーゼという酵素の欠乏の結果、臓器不全が増加します。ファブリー病の根本的な原因は、脂肪物質の一種であるグロボトリアオシルセラミドの異常蓄積にあります。市場成長の要因としては、ファブリー病の患者数の拡大、基質低減療法や遺伝子治療の普及などが挙げられます。

全米ファブリー病財団（NFDF）は、毎年4月をファブリー病教育月間と定めています。さらに、ファブリーオーストラリア、ファブリー国際ネットワーク（FIN）、英国のMPS協会などが、4月をファブリー疾患啓発月間と正式に定めています。さらに、これらの団体は4月の間、ファブリー病に対する認識を高めています。これには、一般の人々、顧客、介護者、専門医への教育も含まれます。また、ファブリー病の研究開発の増加により、市場も拡大しています。ファブリー病の研究開発は、世界中の組織から継続的に資金提供されています。例えば、ファブリー病研究のためのスマート機能性GLA-ナノ製剤は、Horizon 2020 Framework Programme（H2020）（Smart-4-Fabry）によって支援されました。このプロジェクトは2017年に開始され、直近のワークショップは2021年2月に開催されました。しかし、2022年から2029年の予測期間を通じて、新興国の市場成長における診断リソースの不足が指摘されています。

世界のファブリー病治療薬市場の調査において考慮された主要地域は、アジア太平洋、北米、欧州、中南米、その他の地域です。北米は、ファブラザイムというブランドの高い使用率と、ファブリー病の早期診断に関連する認知度の広まりにより、市場全体のシェアを独占すると予想されます。一方、アジア太平洋地域は、ヘルスケア支出の増加とファブリー病治療薬市場の成長により、最も急速に成長している地域であると予測されます。

本調査の目的は、近年における様々なセグメントおよび国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国における産業の質的および量的側面を取り入れるよう設計されています。

また、市場の将来的な成長を定義する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

• 市場スナップショット
• 世界・セグメント別市場推定・予測、2019-2029年
  • ファブリー病治療薬市場（地域別）：2019-2029年
  • ファブリー病治療薬市場：治療法別、2019-2029年
  • ファブリー病治療薬市場：投与経路別、2019-2029年
  • ファブリー病治療薬市場：流通チャネル別、2019-2029年
• 主な動向
• 調査手法の紹介
• 調査前提条件

第2章 ファブリー病治療薬の世界市場定義と範囲

• 調査の目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 調査対象年
• 通貨換算レート

第3章 ファブリー病治療薬の世界市場力学

• ファブリー病治療薬市場のインパクト分析（2019-2029年）
  • 市場促進要因
    • ファブリー病に関する認知度の上昇
    • 基質低減療法や遺伝子治療の人気の高まり
  • 市場の課題
    • 新興国における診断リソースの不足
  • 市場機会
    • 有利な政府のヘルスケア政策
    • ファブリー病治療に関連する研究開発の増加

第4章 世界のファブリー病治療薬市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • 社会的
  • 技術的
• 投資採用モデル
• アナリストの結論・提言
• トップ投資機会
• 主要成功戦略

第5章 リスク評価：COVID-19のインパクト

• COVID-19が業界に与える全体的な影響の評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 ファブリー病治療薬の世界市場：治療別

• 市場スナップショット
• ファブリー病治療薬の世界市場：治療別、実績-ポテンシャル分析
• ファブリー病治療薬の世界市場、治療別推定・予測2019～2029年
• ファブリー病治療薬市場、サブセグメント分析
  • 酵素補充療法
  • 経口シャペロン療法
  • その他の治療法

第7章：ファブリー病治療薬の世界市場：投与経路別

• 市場スナップショット
• ファブリー病治療薬の世界市場：投与経路別実績-ポテンシャル分析
• ファブリー病治療薬の世界市場、投与ルート別推定・予測（2019-2029年
• ファブリー病治療薬市場、サブセグメント分析
  • 経口投与ルート
  • 静脈内投与ルート

第8章 ファブリー病治療薬の世界市場：流通チャネル別

• 市場スナップショット
• ファブリー病治療薬の世界市場：流通チャネル別実績-ポテンシャル分析
• ファブリー病治療薬の世界市場、流通チャネル別推定・予測（2019-2029年
• ファブリー病治療薬市場、サブセグメント分析
  • 病院内薬局
  • 小売薬局
  • オンライン薬局

第9章 ファブリー病治療薬の世界市場：地域別分析

• ファブリー病治療薬市場、地域別市場スナップショット
• 北米
  • 米国
    • 治療薬別の推定・予測、2019-2029年
    • 投与経路別の推定・予測、2019-2029年
    • 流通チャネル別の推定・予測、2019年～2029年

カナダファブリー病治療薬市場

• 欧州ファブリー病治療薬市場スナップショット
  • 英国ファブリー病治療薬市場
  • ドイツファブリー病治療薬市場
  • フランスファブリー病治療薬市場
  • スペインファブリー病治療薬市場
  • イタリアファブリー病治療薬市場
  • その他欧州のファブリー病治療薬市場
• アジア太平洋地域のファブリー病治療薬市場スナップショット
  • 中国ファブリー病治療薬市場
  • インドファブリー病治療薬市場
  • 日本ファブリー病治療薬市場
  • オーストラリアファブリー病治療薬市場
  • 韓国ファブリー病治療薬市場
  • その他アジア太平洋地域のファブリー病治療薬市場
• ラテンアメリカのファブリー病治療薬市場スナップショット
  • ブラジルのファブリー病治療薬市場
  • メキシコのファブリー病治療薬市場
• 世界のその他の地域ファブリー病治療薬市場

第10章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Amicus Therapeutics, Inc
    • 主要情報
    • 概要
    • 財務情報（データの入手状況により異なります）
    • 製品概要
    • 最近の動向
  • Sanofi（Genzyme Corporation）
  • Protalix BioTherapeutics
  • JCR Pharmaceuticals Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Freeline Therapeutics Holdings PLC
  • ISU ABXIS
  • Chiesi Farmaceutici S.p.A.
  • BIOSIDUS
  • Avrobio, Inc.

第11章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査属性
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Fabry Disease Treatment Market, report scope
• TABLE 2. Global Fabry Disease Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Fabry Disease Treatment Market estimates & forecasts by Treatment 2019-2029 (USD Billion)
• TABLE 4. Global Fabry Disease Treatment Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
• TABLE 5. Global Fabry Disease Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
• TABLE 6. Global Fabry Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Fabry Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Fabry Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Fabry Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Fabry Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Fabry Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Fabry Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Fabry Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Fabry Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Fabry Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. U.S. Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 20. Canada Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. Canada Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 23. UK Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. UK Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 26. Germany Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. Germany Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 29. France Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. France Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 32. Italy Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Italy Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 35. Spain Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. Spain Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 38. RoE Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. RoE Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 41. China Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. China Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 44. India Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. India Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 47. Japan Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. Japan Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 50. South Korea Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. South Korea Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 53. Australia Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. Australia Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. RoAPAC Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 59. Brazil Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Brazil Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 62. Mexico Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. Mexico Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 65. RoLA Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. RoLA Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Fabry Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 68. Row Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. Row Fabry Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Fabry Disease Treatment Market
• TABLE 71. List of primary sources, used in the study of global Fabry Disease Treatment Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Fabry Disease Treatment Market, research methodology
• FIG 2. Global Fabry Disease Treatment Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Fabry Disease Treatment Market, key trends 2021
• FIG 5. Global Fabry Disease Treatment Market, growth prospects 2022-2029
• FIG 6. Global Fabry Disease Treatment Market, porters 5 force model
• FIG 7. Global Fabry Disease Treatment Market, pest analysis
• FIG 8. Global Fabry Disease Treatment Market, value chain analysis
• FIG 9. Global Fabry Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Fabry Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Fabry Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Fabry Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Fabry Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Fabry Disease Treatment Market, regional snapshot 2019 & 2029
• FIG 15. North America Fabry Disease Treatment Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Fabry Disease Treatment Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Fabry Disease Treatment Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Fabry Disease Treatment Market 2019 & 2029 (USD Billion)
• FIG 19. Global Fabry Disease Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Fabry Disease Treatment Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.8% over the forecast period 2022-2029. Lysosomal storage disorders are a class of diseases that includes Fabry disease. It is an uncommon hereditary condition that can impact the kidneys, heart, skin, and other organs. The patient has increasing organ failure as a result of a deficiency in the enzyme alpha-galactosidase. The fundamental cause of Fabry disease is the abnormal buildup of globotriaosylceramide, a specific type of fatty substance. Factors contributing towards the market growth include expanding base of patients suffering from Fabry disease and the growing popularity of substrate reduction therapies and gene therapies.

The National Fabry Disease Foundation (NFDF) states that "April" is recognized as Fabry Disease Awareness Month each year. Additionally, Fabry Australia, Fabry International Network (FIN), and MPS Society in the UK are among the organizations that formally mark April as Fabry Disease Awareness Month. Additionally, these groups increase Fabry disease awareness during the month of April. This includes educating members of the public, clients, caregivers, and medical specialists. The market is also expanding because of an increase in Fabry disease research and development. Fabry disease research and development are continuously funded by organizations across the globe. For instance, the Smart functional GLA-nano formulation for the Fabry disease study was supported by the Horizon 2020 Framework Programme (H2020) (Smart-4-Fabry). The project was initiated in 2017, and its most recent workshop was held in February 2021. However, a lack of diagnostic resources in emerging country's market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Fabry Disease Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is expected to dominate the overall market share owing to high usage of the brand Fabrazyme and widespread of awareness related to early diagnosis of Fabry disease. However, Asia Pacific is projected to be the fastest growing region due to rise in the healthcare expenditure and growth in the Fabry disease drug market.

Major market players included in this report are:

Amicus Therapeutics, Inc

Sanofi (Genzyme Corporation)

Protalix BioTherapeutics

JCR Pharmaceuticals Co., Ltd.

Takeda Pharmaceutical Company Limited

Freeline Therapeutics Holdings PLC

ISU ABXIS

Chiesi Farmaceutici S.p.A.

BIOSIDUS

Avrobio, Inc.

Recent Developments in the Market:

• Chiesi Farmaceutici S.p.A. announced the launch of a new business unit called Chiesi Global Rare Diseases in February 2020. Additionally, the aim of this newly established business unit is to perform cutting-edge research and develop innovative products for the treatment of uncommon and ultra-rare diseases, including lysosomal storage disorders such as Fabry disease.
• Micus Therapeutics is becoming a major participant in the field of rare diseases with the introduction of Galafold, the first oral therapy for Fabry disease. Due to the expanding popularity of substrate reduction treatments and gene therapies in the market and the probable introduction of their respective pipeline medicines, lucerastat and AVR-RD-01, Idorsia and Avrobio are also anticipated to command a significant market share.

Global Fabry Disease Treatment Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Treatment, Route of Administration, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment:

Enzyme Replacement Therapy

Oral Chaperone Therapy

Other Treatments

By Route of Administration:

Oral Route

Intravenous Route

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Fabry Disease Treatment Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Fabry Disease Treatment Market, by Treatment, 2019-2029 (USD Billion)
  • 1.2.3. Fabry Disease Treatment Market, by Route of Administration, 2019-2029 (USD Billion)
  • 1.2.4. Fabry Disease Treatment Market, by Distribution Channel, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Fabry Disease Treatment Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Fabry Disease Treatment Market Dynamics

• 3.1. Fabry Disease Treatment Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising awareness regarding Fabry disease
    • 3.1.1.2. Growing popularity of substrate reduction therapies and gene therapies
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack of diagnostic resources in emerging countries
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Favourable governmental healthcare policies
    • 3.1.3.2. Rise in research and development related to Fabry disease treatment

Chapter 4. Global Fabry Disease Treatment Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Fabry Disease Treatment Market, by Treatment

• 6.1. Market Snapshot
• 6.2. Global Fabry Disease Treatment Market by Treatment, Performance - Potential Analysis
• 6.3. Global Fabry Disease Treatment Market Estimates & Forecasts by Treatment 2019-2029 (USD Billion)
• 6.4. Fabry Disease Treatment Market, Sub Segment Analysis
  • 6.4.1. Enzyme Replacement Therapy
  • 6.4.2. Oral Chaperone Therapy
  • 6.4.3. Other Treatments

Chapter 7. Global Fabry Disease Treatment Market, by Route of Administration

• 7.1. Market Snapshot
• 7.2. Global Fabry Disease Treatment Market by Route of Administration, Performance - Potential Analysis
• 7.3. Global Fabry Disease Treatment Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
• 7.4. Fabry Disease Treatment Market, Sub Segment Analysis
  • 7.4.1. Oral Route
  • 7.4.2. Intravenous Route

Chapter 8. Global Fabry Disease Treatment Market, by Distribution Channel

• 8.1. Market Snapshot
• 8.2. Global Fabry Disease Treatment Market by Distribution Channel, Performance - Potential Analysis
• 8.3. Global Fabry Disease Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
• 8.4. Fabry Disease Treatment Market, Sub Segment Analysis
  • 8.4.1. Hospital Pharmacies
  • 8.4.2. Retail Pharmacies
  • 8.4.3. Online Pharmacies

Chapter 9. Global Fabry Disease Treatment Market, Regional Analysis

• 9.1. Fabry Disease Treatment Market, Regional Market Snapshot
• 9.2. North America Fabry Disease Treatment Market
  • 9.2.1. U.S. Fabry Disease Treatment Market
    • 9.2.1.1. Treatment breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029

Canada Fabry Disease Treatment Market

• 9.3. Europe Fabry Disease Treatment Market Snapshot
  • 9.3.1. U.K. Fabry Disease Treatment Market
  • 9.3.2. Germany Fabry Disease Treatment Market
  • 9.3.3. France Fabry Disease Treatment Market
  • 9.3.4. Spain Fabry Disease Treatment Market
  • 9.3.5. Italy Fabry Disease Treatment Market
  • 9.3.6. Rest of Europe Fabry Disease Treatment Market
• 9.4. Asia-Pacific Fabry Disease Treatment Market Snapshot
  • 9.4.1. China Fabry Disease Treatment Market
  • 9.4.2. India Fabry Disease Treatment Market
  • 9.4.3. Japan Fabry Disease Treatment Market
  • 9.4.4. Australia Fabry Disease Treatment Market
  • 9.4.5. South Korea Fabry Disease Treatment Market
  • 9.4.6. Rest of Asia Pacific Fabry Disease Treatment Market
• 9.5. Latin America Fabry Disease Treatment Market Snapshot
  • 9.5.1. Brazil Fabry Disease Treatment Market
  • 9.5.2. Mexico Fabry Disease Treatment Market
• 9.6. Rest of The World Fabry Disease Treatment Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Amicus Therapeutics, Inc
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Sanofi (Genzyme Corporation)
  • 10.2.3. Protalix BioTherapeutics
  • 10.2.4. JCR Pharmaceuticals Co., Ltd.
  • 10.2.5. Takeda Pharmaceutical Company Limited
  • 10.2.6. Freeline Therapeutics Holdings PLC
  • 10.2.7. ISU ABXIS
  • 10.2.8. Chiesi Farmaceutici S.p.A.
  • 10.2.9. BIOSIDUS
  • 10.2.10. Avrobio, Inc.

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption